查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
床旁分子诊断市场 - 增长、未来展望、竞争分析，2023 年至 2031 年
市场调查报告书
商品编码
1255967

床旁分子诊断市场 - 增长、未来展望、竞争分析，2023 年至 2031 年

Point of Care Molecular Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

在 2023 年至 2031 年的预测期内，全球即时分子诊断市场预计将以 8.5% 的复合年增长率增长。 床旁分子诊断市场的兴起主要是由于传染病和癌症的流行率不断上升，以及终端用户因其吸引人的特性而对床旁分子检测的需求不断增加。 长期以来，医疗专业人员一直在实验室和其他医疗机构中使用分子诊断技术。 然而，高昂的测试成本、耗时的测试以及分子诊断的延迟发现促使人们寻找替代诊断方法。 在此背景下，床旁型分子诊断药物市场备受瞩目。 由于床旁分子诊断能够缩短周转时间并提供快速、可靠的结果，因此在包括医院和研究实验室在内的垂直最终用途中获得了巨大的吸引力。 床旁分子检测可以在实验室外对疾病进行快速和早期诊断。 通常，这些测试是在患者附近进行的。

推动床旁分子诊断市场增长的一个关键因素是越来越多地使用床旁分子诊断解决方案来早期检测各种疾病，从呼吸系统疾病和癌症到性传播疾病疾病和胃肠道疾病。招聘人数正在增加。 展望未来，在新兴国家健康意识提高的推动下，分子诊断和分子成像市场的快速扩张有望为床旁分子诊断製造商创造机会。 除了微流控技术和基因序列分析的最新进展外，低成本、快速的 POC 分子诊断平台的开发有望促进 POC 分子诊断设备的销售并扩大分子 POC 检测市场。

感染和恶性肿瘤的频率增加

发达国家和新兴国家传染病和癌症发病率的上升将对床旁分子诊断市场的增长产生积极影响。 分子诊断的处方频率增加是由于这些疾病的诊断和治疗。 预计在预测期内，上述原因和预防医学的上升趋势将推动对即时分子诊断的需求。

新兴国家的业务扩张机会

印度、韩国、巴西和墨西哥等新兴经济体为床旁分子诊断领域的市场进入者提供了巨大的增长潜力。 这是由于监管障碍低、医疗基础设施的进步、患者数量增加、传染病流行以及医疗成本上升。 此外，这些国家的监管政策比发达国家的监管政策更具适应性和商业友好性。

不利的还款情况限制了市场增长

医疗报销不足是抑制临床分子诊断市场增长的主要因素。 让医疗保险和私人医疗支付者为诊断测试付费是大多数诊断测试商业化的主要障碍。 2018 年，美国医疗保险更新了多项 IVD 检测的资助流程，包括床旁分子诊断。 其中一些测试使用未註册的医疗保健通用程序编码系统 (HCPCS) 代码计费。 在这些情况下，Medicare Managed Contractor (MAC) 设定应付给每个市政当局的金额。 CMS 已将其基于高通量技术的 COVID-19 测试的医疗保险支付率降至 75 美元，除非实验室可以在两天内处理结果。 Medicare 目前不资助没有癌症家族史的人进行基因检测（来源：美国临床肿瘤学会）。

按应用，传染病引领市场

分子诊断中的 PoC 测试有许多应用，包括传染病控制、肿瘤学、血液学、产前筛查和内分泌学中的临近患者测试。 在传染病和肿瘤学领域，床旁 (PoC) 分子检测取得了最大的基于应用的进步。 到 2022 年，传染病领域的收入份额将最大。 传染病的快速分子诊断测试有助于通过提供和促进适当的抗生素治疗、加快疾病控制、加强医疗实验室资产的分配、降低死亡率和医疗支出来增加收入份额。

就技术而言，基于 PCR 的检测引领市场

按技术划分，床旁分子诊断市场分为基于 PCR、基于基因序列、基于杂交和基于微阵列的测试和设备。 到 2022 年，基于 PCR 的测试将占据最大的收入份额。 市场将受到床旁诊断商业化的推动，这些诊断能够对 H1N1 和流感等传染病进行准确、快速的实时 PCR 分析。 由于该行业的众多进步，预计在预测期内，贴近患者的基于 NGS 的分子检测将出现显着增长。 创新的平台改进能够在即时护理和快速诊断中实现高度准确的基因测序和 DNA 数据处理，这有助于该细分市场的预期增长。 由于市场领导者的持续创新和研发努力，快速 DNA 分析有望在未来几年内实现显着增长。

在预测期内，OTC 测试将按测试地点主导市场

市场分为概念验证 (PoC) 和场外交易 (OTC) 测试，具体取决于测试地点。 OTC 测试的多功能性和便携性优于家庭和疗养院使用的 POC 测试。 大多数 OTC 用户是未经培训的专业人员，在大多数情况下，是患者本人。 此外，其中许多测试都是 CLIA 豁免的，鼓励非实验室使用。 由于其易用性、可访问性和高采用率，预计场外交易 (OTC) 测试将在预测期内产生可观的收入。

在最终用户方面，分布式实验室引领市场

按最终用途，市场分为分布式实验室、医院、家庭护理、辅助医疗设施等。 到 2022 年，分布式实验室将获得最大的收入份额。 与基于中央实验室的同行相比，这些测试的物理足迹要小得多，而且它们提供快速准确的分子分析的能力是该领域收入份额增长的关键驱动力。

亚太地区仍然是增长最快的地区

市场进入者的不懈努力对增加市场份额做出了重大贡献。 此外，许多临床研究验证了新型分子测试的有效性和准确性，预计将有助于在预测期内扩大市场。 对快速诊断的日益增长的需求以及用于 DNA 分析的创新分子诊断方法的引入使欧洲成为一个重要的利基市场。 由于缺乏先进的中央实验室检测服务、需要临床检测的大量人口以及引入具有成本效益的 PoC 分子检测的潜力，亚太地区将在预测期内实现最高增长。预计将创下记录。

内容

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要产品
  • 市场细分
  • 调查方法
    • 第一阶段 - 二次调查
    • 第二阶段 - 初步研究
    • 第三阶段 - 专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

  • 市场概况：全球床旁分子诊断市场
  • 全球床旁分子诊断市场：按产品和服务分类，2022 年
  • 全球床旁分子诊断市场：按技术分类，2022 年
  • 全球床旁分子诊断市场：按应用分类，2022 年
  • 全球床旁分子诊断市场：按最终用户分类，2022 年
  • 全球床旁分子诊断市场：按地区划分，2022 年
  • 有吸引力的投资建议：按地区划分，2022 年

第 3 章床旁分子诊断市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采用的策略
  • 主要产业战略
  • 等级分析：2022 年与 2031 年

第 4 章护理点分子诊断市场：宏观分析和市场动态

  • 简介
  • 2021-2031 年全球床旁分子诊断市场价值
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章护理点分子诊断市场：按产品和服务分类，2021 年至 2031 年

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 化验和试剂盒
    • 仪器和分析仪
    • 软件和服务

第 6 章护理点分子诊断市场：按技术分类，2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • RT-PCR
    • 惰性
    • 其他技术

第 7 章护理点分子诊断市场：按应用分类，2021 年至 2031 年

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 呼吸系统疾病
    • 性传播疾病
    • 院内感染
    • 癌症
    • 肝炎
    • 胃肠道疾病
    • 其他应用

第 8 章护理点分子诊断市场：按最终用户分类，2021 年至 2031 年

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 医务室
    • 医院和 ICU
    • 调查
    • 其他最终用户

第 9 章北美护理点分子诊断市场 2021-2031

  • 市场概览
  • 床旁分子诊断市场：2021-2031 年（按产品和服务）
  • 床旁分子诊断市场：2021-2031 年（按技术）
  • 床旁分子诊断市场：按应用分类，2021 年至 2031 年
  • 床旁分子诊断市场：按最终用户划分，2021-2031 年
  • 床旁分子诊断市场：2021-2031 年（按地区划分）
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 10 章英国和欧盟护理点分子诊断市场 2021-2031

  • 市场概览
  • 床旁分子诊断市场：按产品/服务分类，2021 年-2031年
  • 床旁分子诊断市场：2021-2031 年（按技术）
  • 床旁分子诊断市场：按应用分类，2021 年至 2031 年
  • 床旁分子诊断市场：按最终用户划分，2021-2031 年
  • 床旁分子诊断市场：2021-2031 年（按地区划分）
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 11 章亚太护理点分子诊断市场 2021-2031

  • 市场概览
  • 床旁分子诊断市场：2021-2031 年（按产品和服务）
  • 床旁分子诊断市场：2021-2031 年（按技术）
  • 床旁分子诊断市场：按应用分类，2021 年至 2031 年
  • 床旁分子诊断市场：按最终用户划分，2021-2031 年
  • 床旁分子诊断市场：2021-2031 年（按地区划分）
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第 12 章拉丁美洲护理点分子诊断市场 2021-2031

  • 市场概览
  • 床旁分子诊断市场：2021-2031 年（按产品和服务）
  • 床旁分子诊断市场：2021-2031 年（按技术）
  • 床旁分子诊断市场：按应用分类，2021 年至 2031 年
  • 床旁分子诊断市场：按最终用户划分，2021-2031 年
  • 床旁分子诊断市场：2021-2031 年（按地区划分）
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第 13 章中东和非洲护理点分子诊断市场 2021-2031

  • 市场概览
  • 床旁分子诊断市场：2021-2031 年（按产品和服务）
  • 床旁分子诊断市场：2021-2031 年（按技术）
  • 床旁分子诊断市场：按应用分类，2021 年至 2031 年
  • 床旁分子诊断市场：按最终用户划分，2021-2031 年
  • 床旁分子诊断市场：2021-2031 年（按地区划分）
    • 中东和非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东和非洲地区

第14章公司简介

  • Abbott Laboratories（U.S.）
  • F. Hoffmann-La Roche Ltd.（Switzerland）
  • bioMerieux S.A.（France）
  • Danaher Corporation（U.S.）
  • Quidel Corporation（U.S.）
  • QIAGEN N.V.（Netherlands）
  • Co-Diagnostics Inc.
  • Biocartis NV（Belgium）
  • Meridian Bioscience Inc.（U.S.）
  • Thermo Fisher Scientific Inc.（U.S.）
Product Code: 139508-04-23

The global market for point-of-care molecular diagnostics is anticipated to expand at a CAGR of 8.5% during the forecast period of 2023 and 2031. The rise of the point-of-care molecular diagnostics market is primarily driven by the increasing prevalence of infectious diseases and cancer, as well as the growing desire of end users for point-of-care molecular testing due to its attractive features. Medical personnel has long utilized molecular diagnostics in laboratories and other healthcare settings. However, the expensive cost of testing, the time-consuming nature, and the delayed findings of molecular diagnostics has encouraged them to seek out alternative diagnostic methods. This has brought the market for molecular diagnostics at the point-of-care into the limelight. Point-of-care molecular diagnostics has acquired significant traction across end-use verticals, including hospitals and research institutes, due to its ability to cut turnaround time and deliver reliable results quickly. Molecular testing at the point of care enables the rapid and early diagnosis of illnesses in non-laboratory settings. Typically, these tests are administered at the locations of close patients.

A key factor driving the growth of the point-of-care molecular diagnostics market is the increasing adoption of point-of-care molecular diagnostic solutions for the early detection of a wide range of diseases, from respiratory diseases and cancer to sexually transmitted diseases and gastrointestinal disorders. In the future years, the rapid expansion of the molecular diagnostics and molecular imaging markets, fueled by rising health consciousness in emerging nations, will generate possibilities for point-of-care molecular diagnostics producers. In addition, recent advances in microfluidics and genetic sequencing, along with the development of low-cost and speedy point-of-care molecular diagnostic platforms, will increase sales of POC molecular diagnostics devices, thereby growing the market for molecular POC tests.

Rising Frequency of Infectious and Malignant Diseases

The rising incidence of infectious diseases and cancer in both developed and emerging regions will favorably impact the growth of the market for point-of-care molecular diagnostics. The increasing frequency of prescriptions for molecular diagnostic tests is attributable to the diagnosis and treatment of such disorders. Demand for point-of-care molecular diagnostics is anticipated to be driven over the projected period by the aforementioned causes and the growing trend toward preventive medicine.

Opportunities For Expansion in Emerging Nations

Emerging economies such as India, South Korea, Brazil, and Mexico present substantial growth potential to market participants in the point-of-care molecular diagnostics sector. This is due to low regulatory hurdles, advancements in healthcare infrastructure, a growing patient population, an increase in the prevalence of infectious diseases, and rising healthcare expenditures. In addition, the regulatory policies of several of these nations are more adaptable and business-friendly than those of developed nations.

Unfavorable Reimbursement Scenario to Limit the Market Growth

Inadequate reimbursements are a major factor inhibiting the growth of the market for molecular diagnostics at the point of care. Getting Medicare and private health insurers to pay for diagnostic testing is a significant obstacle to the commercialization of most diagnostic tests. In 2018, Medicare in the United States updated its funding process for several IVD tests, including point-of-care molecular diagnostics. Several of these tests are billed using unlisted Healthcare Common Procedure Coding System (HCPCS) codes. In such instances, Medicare Administrative Contractors (MACs) establish a payment amount for their respective local governments. CMS cut the Medicare payment rate for COVID-19 tests based on high throughput technology to USD 75 unless laboratories can process findings in less than two days. Medicare does not currently fund genetic testing for those without a cancer family history (Source: American Society of Clinical Oncology).

Infectious Diseases Led the Market by Application

PoC testing in molecular diagnostics has many uses, including testing near the patient in infectious disease management, oncology, hematology, prenatal screening, and endocrinology. In the disciplines of infectious illnesses and oncology, point-of-care (PoC) molecular testing has seen the greatest application-based advancements. In 2022, the infectious diseases segment had the biggest revenue share. Contributing to the revenue share of infectious diseases for rapid molecular diagnostic tests are the provision and facilitation of appropriate antibiotic therapy, faster disease management, enhanced distribution of healthcare laboratory assets, and reductions in mortality and healthcare expenditures.

PCR Based Testing Led the Market by Technology

On the basis of technology, the market for point-of-care molecular diagnostics has been divided into PCR-based, genetic sequencing-based, hybridization-based, and microarray-based tests and devices. In 2022, PCR-based testing generated the greatest revenue share. The market will be driven by the commercialization of point-of-care diagnostics that deliver accurate, rapid real-time PCR analysis for infectious illnesses such as H1N1 and influenza. Due to a number of industry advances, NGS-based molecular testing in close proximity to the patient is expected to have substantial growth during the projection period. Innovative platform modifications that enable genetic sequencing and DNA data processing at the point of care with high precision and give speedy diagnosis contribute to the predicted growth of this market sector. Rapid DNA analysis is anticipated to have substantial growth in the next years as a result of the continuing innovation and R&D efforts of market leaders.

OTC Tests to Dominate During the Forecast Period for Market by Test Site

The market is divided into Proof-of-Concept (PoC) and Over-the-Counter (OTC) tests, depending on the location of the tests. The versatility and portability of OTC tests are superior to POC tests for use in homes and assisted care facilities. The majority of OTC users are untrained professionals and, in the majority of cases, the patients themselves. In addition, a number of these testing instruments are exempt from CLIA, which encourages their use outside of laboratories. Over-the-counter (OTC) tests are anticipated to create more revenue during the projected period due to their usability, accessibility, and higher adoption rate.

Decentralized Laboratories Led the Market by End User

The market is segmented by end-use into decentralized laboratories, hospitals, home care, and assisted living healthcare facilities, among others. In 2022, decentralized laboratories generated the greatest revenue share. The ability of these tests to provide speedy and accurate molecular analysis with a substantially smaller physical footprint than their central laboratory-based equivalents is a crucial driver in the segment's greater revenue share.

APAC to Remain the Fastest Growing Region

Continuous efforts by big market participants to bolster their market position are a significant contributor to the majority share. In addition, a number of clinical studies examining the efficacy and precision of novel molecular tests are anticipated to contribute to the expansion of the market throughout the forecast period. The growing need for speedy diagnosis and the introduction of innovative molecular diagnostic procedures for DNA analysis has positioned Europe as a significant market niche. Due to a lack of advanced central laboratory testing services, a bigger population base requiring clinical testing, and the potential cost-effective implementation of PoC molecular assays, Asia Pacific is predicted to experience the highest growth rate over the forecast period.

Innovations Remain as the Key to Enhance Market Shares

Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMerieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.). These firms are continually concentrating on the development of innovative point-of-care molecular diagnostic platforms, such as the point-of-care molecular COVID test and paper-based nucleic acid amplification assays, which may diagnose diseases with relative simplicity. In addition, they have utilized techniques such as mergers, acquisitions, and alliances, among others, to increase its global presence.

  • In March 2020, Abbott Laboratories will release the ID NOW point-of-care test for coronavirus detection.
  • In July 2021, QuantuMDx introduced Q-POCTM, a fast PCR diagnostic technology for the point of care.
  • Co-Diagnostics, a molecular diagnostics company, successfully acquired Idaho Molecular and Advanced Conceptions in 2022.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Point of Care Molecular Diagnostics market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Point of Care Molecular Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product & Service

  • Assays & kits
  • Instruments &Analyzers
  • Software & Services

Technology

  • RT-PCR
  • INAAT
  • Other technologies

Application

  • Respiratory Diseases
  • Sexually Transmitted Diseases
  • Hospital-acquired Infections
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Other Applications

End User

  • Physicians' Offices
  • Hospitals & ICUs
  • Research Institutes
  • Other End Users

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Point of Care Molecular Diagnostics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Point of Care Molecular Diagnostics market?
  • Which is the largest regional market for Point of Care Molecular Diagnostics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Point of Care Molecular Diagnostics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Point of Care Molecular Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Point of Care Molecular Diagnostics Market
  • 2.2. Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022 (US$ Million)
  • 2.3. Global Point of Care Molecular Diagnostics Market, By Technology, 2022 (US$ Million)
  • 2.4. Global Point of Care Molecular Diagnostics Market, By Application, 2022 (US$ Million)
  • 2.5. Global Point of Care Molecular Diagnostics Market, By End User, 2022 (US$ Million)
  • 2.6. Global Point of Care Molecular Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Point of Care Molecular Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Point of Care Molecular Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Point of Care Molecular Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Point of Care Molecular Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Point of Care Molecular Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Assays & kits
    • 5.3.2. Instruments &Analyzers
    • 5.3.3. Software & Services

6. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. RT-PCR
    • 6.3.2. INAAT
    • 6.3.3. Other technologies

7. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Respiratory Diseases
    • 7.3.2. Sexually Transmitted Diseases
    • 7.3.3. Hospital-acquired Infections
    • 7.3.4. Cancer
    • 7.3.5. Hepatitis
    • 7.3.6. Gastrointestinal Disorders
    • 7.3.7. Other Applications

8. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Physicians' Offices
    • 8.3.2. Hospitals & ICUs
    • 8.3.3. Research Institutes
    • 8.3.4. Other End Users

9. North America Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 9.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 9.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 9.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 9.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

10. UK and European Union Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 10.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 10.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 10.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 10.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.4.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.5.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.6.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

11. Asia Pacific Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 11.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 11.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 11.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 11.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.4.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.5.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.6.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

12. Latin America Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 12.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 12.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 12.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 12.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

13. Middle East and Africa Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
  • 13.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 13.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 13.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
  • 13.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Abbott Laboratories (U.S.)
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. F. Hoffmann-La Roche Ltd. (Switzerland)
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. bioMerieux S.A. (France)
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Danaher Corporation (U.S.)
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Quidel Corporation (U.S.)
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. QIAGEN N.V. (Netherlands)
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Co-Diagnostics, Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Biocartis NV (Belgium)
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Meridian Bioscience, Inc. (U.S.)
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Thermo Fisher Scientific, Inc. (U.S.)
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Others
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 2 Global Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 3 Global Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 4 Global Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 5 North America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 6 North America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 7 North America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 8 North America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 9 U.S. Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 10 U.S. Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 11 U.S. Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 12 U.S. Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 13 Canada Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 14 Canada Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 15 Canada Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 16 Canada Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 17 Rest of North America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 19 Rest of North America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 20 Rest of North America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 21 UK and European Union Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 23 UK and European Union Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 24 UK and European Union Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 25 UK Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 26 UK Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 27 UK Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 28 UK Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 29 Germany Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 30 Germany Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 31 Germany Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 32 Germany Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 33 Spain Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 34 Spain Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 35 Spain Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Spain Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 37 Italy Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 38 Italy Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 39 Italy Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 40 Italy Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 41 France Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 42 France Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 43 France Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 44 France Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 45 Rest of Europe Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 47 Rest of Europe Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 48 Rest of Europe Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 49 Asia Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 50 Asia Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 51 Asia Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 52 Asia Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 53 China Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 54 China Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 55 China Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 56 China Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 57 Japan Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 58 Japan Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 59 Japan Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Japan Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 61 India Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 62 India Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 63 India Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 64 India Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 65 Australia Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 66 Australia Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 67 Australia Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 68 Australia Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 69 South Korea Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 70 South Korea Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 71 South Korea Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 72 South Korea Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 73 Latin America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 74 Latin America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 75 Latin America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 76 Latin America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 77 Brazil Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 78 Brazil Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 79 Brazil Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 80 Brazil Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 81 Mexico Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 82 Mexico Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 83 Mexico Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 84 Mexico Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 85 Rest of Latin America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 87 Rest of Latin America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 88 Rest of Latin America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 89 Middle East and Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 91 Middle East and Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 92 Middle East and Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 93 GCC Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 94 GCC Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 95 GCC Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 96 GCC Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 97 Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 98 Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 99 Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 100 Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Point of Care Molecular Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Point of Care Molecular Diagnostics Market: Quality Assurance
  • FIG. 5 Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022
  • FIG. 6 Global Point of Care Molecular Diagnostics Market, By Technology, 2022
  • FIG. 7 Global Point of Care Molecular Diagnostics Market, By Application, 2022
  • FIG. 8 Global Point of Care Molecular Diagnostics Market, By End User, 2022
  • FIG. 9 Global Point of Care Molecular Diagnostics Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global Point of Care Molecular Diagnostics Market, 2022
  • FIG. 11 Market Positioning of Key Point of Care Molecular Diagnostics Market Players, 2022
  • FIG. 12 Global Point of Care Molecular Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022 Vs 2031, %
  • FIG. 14 Global Point of Care Molecular Diagnostics Market, By Technology, 2022 Vs 2031, %
  • FIG. 15 Global Point of Care Molecular Diagnostics Market, By Application, 2022 Vs 2031, %
  • FIG. 16 Global Point of Care Molecular Diagnostics Market, By End User, 2022 Vs 2031, %
  • FIG. 17 U.S. Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 UK Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 France Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 China Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 India Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031